Optimizing the diagnosis and the treatment of iron overload diseases

Iron therapy in chronic kidney disease: Recent changes, benefits and risks

(2016) Sandra Ribeiro et al.   BLOOD REVIEWS

Iron metabolism and related genetic diseases: A cleared land, keeping mysteries

(2016) Pierre Brissot et al.   JOURNAL OF HEPATOLOGY

Iron deficiency anaemia

(2016) Anthony Lopez et al.   LANCET

Combination therapy with aTmprss6RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia

(2015) Paul J. Schmidt et al.   AMERICAN JOURNAL OF HEMATOLOGY

Eighty percent of French sport winners in Olympic, World and Europeans competitions have mutations in the hemochromatosis HFE gene

(2015) Olivier Hermine et al.   BIOCHIMIE

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

(2015) Yesim Aydinok et al.   BLOOD

Estimating tissue iron burden: current status and future prospects

(2015) John C. Wood   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients

(2015) Mohsen S. Elalfy et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)

(2015) Graça Porto et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data

(2015) Daniel F. Wallace et al.   GENETICS IN MEDICINE

Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous b1/b2 globin gene deletion) mice

(2015) M. P. Gelderman et al.   HAEMATOLOGICA

Reply

(2015) Christine E. McLaren et al.   HEPATOLOGY

Next-generation sequencing: Application of a novel platform to analyze atypical iron disorders

(2015) Cameron J. McDonald et al.   JOURNAL OF HEPATOLOGY

Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload

(2015) Subhash K. Das et al.   LIVER INTERNATIONAL

Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis

(2015) Ludivine Legros et al.   LIVER INTERNATIONAL

Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous b1/b2 globin gene deletion) mice

(2015) M. P. Gelderman et al.   HAEMATOLOGICA

Erythroferrone contributes to recovery from anemia of inflammation

(2014) L. Kautz et al.   BLOOD

Iron chelation

(2014) Sujit Sheth   CURRENT OPINION IN HEMATOLOGY

The Pathophysiology of Transfusional Iron Overload

(2014) John B. Porter et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis

(2014) F. Stickel et al.   HUMAN MOLECULAR GENETICS

Identification of erythroferrone as an erythroid regulator of iron metabolism

(2014) Léon Kautz et al.   NATURE GENETICS

Aceruloplasminemia

(2014) Hiroaki Miyajima   NEUROPATHOLOGY

Hépatosidérose dysmétabolique : une maladie générale ?

(2014) Yves Deugnier et al.   PRESSE MEDICALE

Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major

(2014) A. John Baksi et al.   Frontiers in Pharmacology

The liver: conductor of systemic iron balance

(2013) D. Meynard et al.   BLOOD

Manipulation of the hepcidin pathway for therapeutic purposes

(2013) E. Fung et al.   HAEMATOLOGICA

Increased Height in HFE Hemochromatosis

(2013) Pietro E. Cippà et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systemic Iron Homeostasis

(2013) Tomas Ganz   PHYSIOLOGICAL REVIEWS

Non-HFE hemochromatosis: Pathophysiological and diagnostic aspects

(2013) Edouard Bardou-Jacquet et al.   Clinics and Research in Hepatology and Gastroenterology

Diagnosis and treatment of hereditary hemochromatosis: an update

(2013) Pushpjeet Kanwar et al.   Expert Review of Gastroenterology & Hepatology

Second round robin for plasma hepcidin methods: First steps toward harmonization

(2012) Joyce J.C. Kroot et al.   AMERICAN JOURNAL OF HEMATOLOGY

Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis

(2012) E. Ramos et al.   BLOOD

Iron overload in non-transfusion-dependent thalassemia: a clinical perspective

(2012) Khaled M. Musallam et al.   BLOOD REVIEWS

A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine

(2012) Behjat Moayedi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment

(2012) Claire Larroche   JOINT BONE SPINE

Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis

(2012) Luca Valenti et al.   JOURNAL OF HEPATOLOGY

Haemochromatosis: The bone and the joint

(2011) Pascal Guggenbuhl et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Non-transferrin bound iron: A key role in iron overload and iron toxicity

(2011) Pierre Brissot et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 Years

(2011) Yves Deugnier et al.   GASTROENTEROLOGY

Pathology of Hepatic Iron Overload

(2011) Yves Deugnier et al.   SEMINARS IN LIVER DISEASE

Advances in metal-induced oxidative stress and human disease

(2011) Klaudia Jomova et al.   TOXICOLOGY

Iron disorders of genetic origin: a changing world

(2011) Pierre Brissot et al.   TRENDS IN MOLECULAR MEDICINE

Impact of Iron Assessment by MRI

(2011) J. C. Wood   Hematology-American Society of Hematology Education Program

HJV Hemochromatosis, Iron Overload, and Hypogonadism in a Brazilian Man: Treatment with Phlebotomy and Deferasirox

(2010) Paulo Caleb J.L. Santos et al.   ACTA HAEMATOLOGICA

Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment

(2010) Pierre Brissot et al.   TRANSFUSION

Hyperferritinémies non hémochromatosiques

(2009) Y. Deugnier et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis

(2009) M.-L. Island et al.   HAEMATOLOGICA

Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

(2008) Katrina J. Allen et al.   NEW ENGLAND JOURNAL OF MEDICINE